• Evogene shareholders voted Sept. 4, 2026 to reconstitute the board, effective at the close of the annual meeting.
• Board members: Nir Nimrodi, Adrian Percy, Leon Y. Recanati, Dan Falk, Yael Margolin, Yoshinori Oikawa, Ofer Haviv.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Evogene Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001178913-26-004425), on September 04, 2026, and is solely responsible for the information contained therein.